| http://www.w3.org/ns/prov#value | - To date approximately 1,900 patients have agreed to participate, including patients with cirrhosis and other populations underrepresented in clinical trials. ???The data coming out of the HCV-TARGET consortium will help inform physicians and patients as they weigh important decisions regarding therapy, decisions that can greatly impact quality of life,??? said Dr. Donald M. Jensen, a professor of
|
